Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Kidney Disease Clinical Trials in Houston | 205 Studies

Clinical Trials Kidney DiseaseHouston

Kidney Disease Clinical Trials in Houston

Find 205 clinical trials for kidney disease near Houston, Texas. Connect with research centers in your area.

All Kidney Disease trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 121-140 of 205 trials

CompletedAnemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)This Phase 3 study in hemodialysis-dependent subjects with anemia will evaluate the efficacy and safety of daprodustat administered three-times weekly compared to epoetin alfa…NCT03400033·Mesa, Arizona and 90 others

Kidney Disease Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

Active not recruitingA Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care SettingThis is an observational study in people with chronic kidney disease (CKD) and type 2 diabetes (T2D) who will be receiving finerenone.NCT05348733·Huntsville, Alabama and 55 others

CompletedDialysis Clinical Outcomes Revisited (DCOR) TrialThis is a randomized, open-label, parallel-design study to be conducted at 75 centers within the United States. The study will be described to hemodialysis patients.NCT00324571·Gadsden, Alabama and 72 others

CompletedA 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on DialysisThis is up to a 58 week study comparing ferric citrate to active control for 52 weeks in ESRD dialysis patients, and subsequently comparing ferric citrate to placebo for 4 weeks.NCT01191255·Tempe, Arizona and 55 others

CompletedSafety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar ControlPrimary Objective: To demonstrate the superiority of Sotagliflozin 200 milligrams (mg) and Sotagliflozin 400 mg versus placebo on HbA1c reduction at 26 Weeks in participants with…NCT03242252·Birmingham, Alabama and 169 others

Active not recruitingFerric Citrate in ESRD Pilot ProjectThis research study is for participants that have End Stage Renal Disease (ESRD). ESRD is the last stage of chronic kidney disease.NCT03055598·Houston, Texas and 1 other

CompletedEvaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) InhibitorProspective, Randomized, Double-Blind, Placebo-Controlled Multicenter Study.NCT01356849·Pell City, Alabama and 71 others

Active not recruitingSPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTNThe purpose of this single-arm interventional study is to evaluate the long-term safety, efficacy, and durability of the Symplicity Spyral system in subjects treated with renal…NCT05198674·Birmingham, Alabama and 96 others

CompletedFerumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease PatientsThe study will evaluate the safety and efficacy of a new intravenously administered iron drug to treat anemia in patients with chronic kidney disease who are not on dialysis.NCT00255424·Encino, California and 18 others

CompletedMaintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934Evaluate efficacy and safety of 16 weeks of titrated dose treatment with BAY85-3934 versus epoetin alfa/beta as measured by hemoglobin (Hb) levels.NCT01975818·Azusa, California and 34 others

CompletedSafety and Efficacy Study of Roxadustat (FG-4592) for the Treatment of Anemia in End-Stage Renal Disease (ESRD) Newly Initiated Dialysis ParticipantsThe purpose of this study is to determine whether roxadustat is safe and effective in the treatment of anemia in participants who have just begun dialysis treatment for ESRD.NCT02052310·Chula Vista, California and 112 others

RecruitingA Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.This is a Phase III, randomized, double-blind, parallel-group, placebo-controlled multicenter study to investigate outcomes with elecoglipron compared with placebo in participants…NCT07753993·Huntsville, Alabama and 714 others

WithdrawnEfficacy and Safety of Volenrelaxin in Adults With Chronic Kidney DiseaseThe main purpose of this study is to investigate the efficacy and safety of Volenrelaxin in adults with Chronic Kidney Disease. The study will last about 24 weeks.NCT06598631·Downey, California and 34 others

TerminatedSevere Renal Disease Study in Fabry Patients Treated With FabrazymeThis study was designed to determine appropriate treatment with Fabrazyme at a biweekly dose of either 1 mg/kg or 3 mg/kg in a population of patients with severe renal disease…NCT00837824·Farmington, Connecticut and 8 others

CompletedPhase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney DiseaseThis study assesses the effects of a new formulation of bardoxolone methyl on eGFR in Patients with Chronic Kidney Disease and Type 2 Diabetes.NCT01053936·Montgomery, Alabama and 25 others

CompletedExtension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on DialysisThe primary objective of this study was to characterize the long-term safety and tolerability of cinacalcet in pediatric patients with chronic kidney disease (CKD) receiving…NCT02341417·Los Angeles, California and 32 others

RecruitingImplementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)IRIS-CKD is an implementation study to improve guideline-recommended screening of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D) in the United States.NCT06906627·Birmingham, Alabama and 6 others

CompletedA Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney DiseaseThis study is open to adults with chronic kidney disease (CKD) that is at risk of getting worse.NCT06926660·Huntsville, Alabama and 156 others

CompletedTo Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe PruritusThe purpose of this study was to evaluate the efficacy of nemolizumab compared to placebo at reducing the intensity of pruritus after a 12-week treatment period in adult…NCT05075408·Bakersfield, California and 63 others

CompletedTacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE ScoreThe TEAMMATE Trial will enroll 210 pediatric heart transplant patients from 25 centers at 6 months post-transplant and follow each patient for 2.5 years.NCT03386539·Birmingham, Alabama and 24 others

PreviousPage 7 of 11Next

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia